Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes MellitusNutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitusRecruitingPhase 1 / Phase 22025-02-06NCT05268237

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Biolingus1
Chinese University of Hong Kong480

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Clinical Trials Unit, Chinese University of Hong KongHong KongHong Kong1